Featuring Vinod Balachandran, MD, Associate Attending, Department of Surgery & member of the Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
In this compelling edition of the Cancer Immunotherapy & You Patient Webinar Series, Dr. Balachandran discusses one of the most exciting frontiers in cancer treatment: cancer vaccines. He breaks down the science behind immunotherapy, explores how vaccines can train the immune system to recognize and fight cancer, and shares promising early results — particularly in challenging diseases like pancreatic cancer.
With a mix of clear explanations and cutting-edge insights, this webinar offers a hopeful look at how personalized vaccines could transform cancer care in the near future.
Watch this webinar to learn:
- What cancer immunotherapy is and how it differs from chemotherapy and targeted therapy
- How the immune system can recognize and attack cancer cells
- The science behind vaccines, including mRNA technology
- Key differences between traditional vaccines and cancer vaccines
- Challenges in developing vaccines for cancer vs. infectious diseases
- Current progress and breakthroughs in mRNA cancer vaccines
- Which cancers are being studied (e.g., melanoma, lung, pancreatic cancer)
- Insights from early clinical trials in pancreatic cancer
- Safety considerations and clinical trial phases
- The future of cancer vaccines: treatment vs. prevention
- The role of personalized (patient-specific) vaccines
- Why new therapies are urgently needed beyond current immunotherapies
Don’t miss this opportunity to explore the limitless potential of emerging technologies in transforming cancer immunotherapy.
